In addition, TF is comparable to CTLA‐4 or PD‐1 antibodies used alone for increasing T cell infiltration and promoting tumor cell apoptosis, while the combination of TF and CTLA‐4 antibodies is more effective (Figure S8C,D). The gene discussed is TF; the disease is neoplasm.